How to Get Humira (adalimumab) Covered by Humana in Michigan: Complete 2025 Guide with Forms and Appeals

Quick Answer: Humana requires prior authorization for Humira (adalimumab) in Michigan, with step therapy mandating trials of preferred biosimilars first. Submit PA via Humana's provider portal with diagnosis documentation, biosimilar failure records, and TB/hepatitis B screening. If denied, you have 65 days to appeal, with Michigan's DIFS external review available within 127 days for non-Medicare plans. Start by gathering your medical records and calling your prescriber today.

Table of Contents

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required Must get approval before filling Humana formulary/provider portal Humana PA Lists
Step Therapy Try biosimilars (Amjevita, Cyltezo) first Part B step therapy policy 2024 Step Therapy List
TB/Hepatitis B Screening Required before starting Lab results in PA submission FDA Humira Label
Appeals Deadline 65 days from denial notice Medicare Part D regulations CMS Appeals Process
Michigan External Review 127 days after final denial DIFS external review form Michigan DIFS Appeals

Step-by-Step: Fastest Path to Approval

1. Verify Your Plan Type and Coverage

Who: Patient
Timeline: Same day
Action: Call the number on your Humana ID card to confirm whether you have Medicare Advantage, Medicare Part D, or commercial coverage. Ask specifically about Humira's formulary status and PA requirements.

2. Gather Required Documentation

Who: Patient and prescriber
Timeline: 1-2 weeks
Documents needed:

  • Complete medical records with diagnosis and ICD-10 codes
  • Documentation of biosimilar trials (Amjevita, Cyltezo) with dates, doses, and failure reasons
  • Recent lab results: TB screening (QuantiFERON-Gold), hepatitis B panel (HBsAg, HBcAb)
  • Current disease activity measures (for RA: DAS28, CDAI; for IBD: Mayo score, CDAI)

3. Document Biosimilar Step Therapy

Who: Prescriber
Timeline: Must show adequate trials
Requirements: Per Humana's step therapy policy, document failure, intolerance, or contraindication to preferred adalimumab biosimilars. Include specific dates, dosing, duration of trials, and reasons for discontinuation.

4. Submit Prior Authorization

Who: Prescriber or clinic staff
Timeline: Allow 72 hours for standard decision
Method: Submit via Humana provider portal or call 800-457-4708
Include: Complete PA form, medical necessity letter, all supporting documentation

5. Request Expedited Review if Urgent

Who: Prescriber
Timeline: 24-72 hours for decision
Criteria: If waiting could seriously harm your health, have your doctor submit a letter stating medical urgency with the PA request.

6. Monitor Decision and Prepare for Appeals

Who: Patient and clinic
Timeline: Track submission date
Action: If no response within 72 hours for standard requests, follow up. If denied, immediately request peer-to-peer review and prepare appeal documentation.

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
Step therapy not completed Document biosimilar failures Trial dates, doses, specific adverse effects or lack of efficacy
Missing safety screening Submit required lab results QuantiFERON-Gold, hepatitis B panel, CBC, liver function tests
Insufficient medical necessity Strengthen clinical justification Disease activity scores, functional assessments, treatment goals
Non-formulary status Request formulary exception Medical necessity letter citing why biosimilars inappropriate
Quantity limits exceeded Justify dosing rationale Weight-based dosing calculations, clinical guidelines
Clinician Corner: Medical Necessity Letter ChecklistPatient's specific diagnosis with ICD-10 codesCurrent disease activity and functional statusPrior therapies tried with specific dates, doses, and outcomesContraindications or allergies to preferred alternativesClinical guidelines supporting Humira use (ACR for RA, AGA for IBD)Monitoring plan and treatment goalsFDA labeling references for approved indications

Appeals Process for Michigan Residents

Internal Appeals (Humana)

Timeline: File within 65 days of denial notice
Decision: 7 calendar days (standard) or 72 hours (expedited)
Method: Submit to Humana Grievances and Appeals, P.O. Box 14546, Lexington, KY 40512-4546 or call member services

Peer-to-Peer Review

When: Request immediately upon denial
Process: Your prescriber calls Humana's medical director
Success rate: 80-85% overturn rate when properly documented
Preparation: Have failure documentation, clinical guidelines, and treatment rationale ready

Michigan External Review (Non-Medicare Plans)

Timeline: 127 days after final internal denial
Process: Submit DIFS External Review Form FIS 0018
Decision: Up to 60 days (72 hours if expedited)
Contact: Michigan DIFS at 877-999-6442

Note: Medicare Advantage and Part D plans follow federal appeals processes, not Michigan's DIFS external review. Verify your plan type before choosing your appeal path.

Cost-Saving Strategies

While Medicare patients cannot use manufacturer copay cards, several assistance options exist:

For Non-Medicare Patients

  • AbbVie Complete Savings Program: Up to $5 copays (verify current terms at AbbVie.com)
  • Patient assistance programs: Income-based free drug programs

For All Patients

  • Medicare Extra Help: Low-income subsidy program
  • HealthWell Foundation: Grants for specialty medications
  • State pharmaceutical assistance programs: Michigan may offer additional support

At Counterforce Health, we help patients navigate these complex coverage decisions by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to identify the specific reasons for denial and drafts point-by-point rebuttals aligned with your plan's own rules.

When to Escalate

Contact Michigan regulators if:

  • Humana violates appeal timelines
  • You believe the denial violates state insurance laws
  • Internal appeals are repeatedly denied without clear justification

Michigan DIFS Contact:
Phone: 877-999-6442
Website: michigan.gov/difs

Frequently Asked Questions

How long does Humana prior authorization take in Michigan?
Standard PA decisions are made within 72 hours. Expedited reviews for urgent cases are completed within 24-72 hours when medical urgency is documented.

What if Humira is non-formulary on my Humana plan?
Request a formulary exception by documenting medical necessity and why preferred alternatives (biosimilars) are inappropriate. Include allergy documentation or prior failure records.

Can I request an expedited appeal in Michigan?
Yes, if waiting for a standard decision could seriously harm your health. Your doctor must provide written documentation of the medical urgency.

Does step therapy apply if I was stable on Humira before joining Humana?
You may qualify for a transition fill (up to 90 days) if you have recent claims showing successful Humira use. Document this with your PA submission.

What's the success rate for Humana appeals in Michigan?
Properly documented appeals citing relevant coverage policies achieve 72-80% overturn rates, with peer-to-peer reviews showing even higher success rates.

How much does Humira cost with Humana coverage?
Costs vary by plan tier. Humira typically falls on the highest specialty tier with copays ranging from $636-$1,513 per fill until you reach the annual out-of-pocket maximum of $2,000 for Medicare Part D.

Can my doctor help with the appeal process?
Yes, your prescriber can file appeals on your behalf with written consent and should participate in peer-to-peer reviews when requested by Humana's medical team.

From Our Advocates: We've seen patients succeed by staying organized and persistent. One Michigan patient with rheumatoid arthritis had their initial Humira denial overturned within two weeks by documenting specific allergic reactions to biosimilar inactive ingredients and providing detailed rheumatologist notes. The key was having complete documentation ready before the appeal deadline.

Sources & Further Reading


Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual circumstances and plan terms. Always consult with your healthcare provider and insurance plan directly for coverage determinations. For additional assistance with insurance appeals and coverage decisions, Counterforce Health provides specialized support in turning denials into successful appeals through evidence-based advocacy.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.